Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

This study has been completed.

Sponsor:

Information provided by:

Centre Hospitalier Universitaire Dijon

ClinicalTrials.gov Identifier:

NCT01020656

First received: November 24, 2009

Last updated: NA

Last verified: November 2009

History: No changes posted

Tracking Information
First Received Date ^ICMJE	November 24, 2009
Last Updated Date	November 24, 2009
Start Date ^ICMJE	January 2009
Primary Completion Date	June 2009 (final data collection date for primary outcome measure)
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	No Changes Posted
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery
Official Title ^ICMJE	Maintenance of Anticoagulant and Antiplatelet Agents for Patients Undergoing Vitreoretinal Surgery
Brief Summary	Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Cohort Time Perspective: Retrospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Non-Probability Sample
Study Population	We analyzed the chart of 239 eyes (206 patients) which underwent posterior segment surgery with peribulbar anesthesia.
Condition ^ICMJE	Retinal Detachment
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	group 1 patients with no anticoagulants used as the control group group 2 patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol) group 3 patients treated with aspirin group 4 patients treated with clopidogrel therapy group 5 patients treated with both anticoagulant and aspirin medications group 6 patients treated with both anticoagulant and clopidogrel medications group 7 patients treated with both aspirin and clopidogrel medications
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE	206
Completion Date	June 2009
Primary Completion Date	June 2009 (final data collection date for primary outcome measure)
Eligibility Criteria ^ICMJE	Inclusion Criteria: Take or no anticoagulant treatment before surgery, Vitreoretinal surgery Exclusion Criteria:none No surgery Anesthetic complication
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	France

Administrative Information
NCT Number ^ICMJE	NCT01020656
Other Study ID Numbers ^ICMJE	MARIE02
Has Data Monitoring Committee	No
Responsible Party	Professor Catherine Creuzot-Garcher, Centre Hospitalier Universitaire Dijon
Study Sponsor ^ICMJE	Centre Hospitalier Universitaire Dijon
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	Centre Hospitalier Universitaire Dijon
Verification Date	November 2009
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top